Immune-modulatory drugs as a novel strategy for the treatment of acute and chronic toxoplasmosis

Project description

Researchers

First name Last name Gender Rank Affiliated Institution Country
Hiba El Hajj Male Associate Professor American University of Beirut Lebanon

Bio: Dr. Hiba El Hajj is currently an Associate Professor at the Department of Experimental Pathology, Immunology and Microbiology, at the Faculty of Medicine of the American University of Beirut. Her main research interests include Molecular Oncology and Molecular Parasitology. In Oncology, her research efforts focus on the concept of targeted therapies on oncoprotein degradation in human hematological malignancies. In Parasitology, she is exploring innovative prevention and treatment strategies using immunomodulatory drugs against toxoplasmosis and cutaneous leishmaniasis. Hiba accrued several national and international prizes and awards including the “2016 Rising Talents L’Oréal UNESCO for Women In Science Award”, and the “2015 L’Oréal UNESCO For Women In Science Levant And Egypt Fellowship”. She also attracted Intramural AUB funding from the Medical Practice Plan, and extramural funding including CNRS-L, CNRS-Montpellier, AUB-CNRS, Cèdre, pharmaceutical companies' funds as well as the “L’Oréal-UNESCO for Women in Science” Awards.

Website

 

Scientific field

Medicine
 

Start Year

2019
 

End Year

2022
 

Social impact

Are you interested in disseminating your research work outside the academic institutions?

No

Are there institutions/organizations contacted you to disseminate your research project?

No